Article

INC Files for IPO

INC Research, a global Phase I to IV contract research organization, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed initial public offering of its common stock.

INC Research, a global Phase I to IV contract research organization, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) related to a proposed initial public offering of its common stock. The number of shares to be offered by INC Research and its stockholders and the price range for the offering have not yet been determined. The Company has applied to list its common stock on The NASDAQ Global Market under the ticker symbol “INCR.”

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.